Fast cancer uptake of 99mTc-labelled bombesin (99mTc BN1)

In Vivo

Volumn 19, Issue 6, 2005, Pages 1071-1076

  Scopinaro, Francesco ^a,b   Di Santo, G P ^a   Tofani, A ^a   Massari, R ^b   Trotta, C ^b   Ragone, M ^c,d   Archimandritis, S ^a   Varvarigou, A D ^e  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ISIB CNR   (Italy)

^d CNR   (Italy)

^e INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

Author keywords

Bombesin; Breast cancer; Gastrinoma; Prostate cancer; Radiolabelled peptides

Indexed keywords

BOMBESIN; TECHNETIUM 99M;

ARTICLE; BLOOD FLOW VELOCITY; BREAST CANCER; CANCER DIAGNOSIS; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; GASTRINOMA; HUMAN; IMAGE SUBTRACTION; ISOTOPE LABELING; LUNG SMALL CELL CANCER; MALE; MATHEMATICAL ANALYSIS; OSCILLATION; PANCREAS CANCER; PLOTS AND CURVES; PROSTATE CANCER; RADIATION DETECTION; RADIOLOGICAL PARAMETERS; REFERENCE VALUE;

EID: 27744592174     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Matsumoto K, Yamada K, Wada E, Hasegawa T, Usui Y and Wada K: Bombesin receptor subtype-3 modulates plasma insulin concentration. Peptides 24(1): 83-90, 2003.
2. Moody TW, Chan D, Fahrenkrug J and Jensen RT: Neuropeptides as autocrine growth factors in cancer cells. Curr Pharm Des 9(6): 495-509, 2003.
3. Cutitta E, Carney DN, Mulsine J, Moody TW, Fedoroko J, Fischler A and Minna JD: Bombesin-like peptides as autocrine growth factors in human small-cell lung cancer. Nature 16: 823-826, 1985.
4. Moody TW and Merali Z: Bombesin-like peptides and associated receptors within the brain: distribution and behavioral implications. Peptides 25(3): 511-520, 2004.
5. Jennings CA, Harrison DC, Maycox PR, Crook B, Smart D and Hervieu GJ: The distribution of the orphan bombesin receptor subtype-3 in the rat CNS. Neuroscience 120(2): 309-324, 2003.
6. Shan L, Emanuel RL, Dewald D, Torday JS, Asokanathan N, Wada K, Wada E and Sunday ME: Bombesin-like peptide receptor gene expression, regulation, and function in fetal murine lung. Am J Physiol Lung Cell Mol Physiol 286(1): L165-173, 2004.
7. Beales IL: Regulation of gastric function by gastrin releasing peptide. Gut 50: 897-898, 2002.
8. Gunal O, Oktar BK, Ozcinar E, Tansuker D, Arbak S and Yegen BC: Healing-promoting effect of bombesin treatment on chronic gastric ulcer in rats. Regul Pept 106: 81-88, 2002.
9. Reubi JC, Wenger S, Schmuckli-Maurer J, Schaer JC and Gugger M: Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14). Clin Cancer Res 8(4): 1139-1146, 2002.
10. Chu KU, Ishizuka J, Battey JF, Uchida T, Beauchamp RD, Townsend CM Jr and Thompson JC: Mechanisms of bombesin on growth of gastrinoma (PT) in vivo. Dig Dis Sci 41: 2180-2186, 1996.
11. Vilches J, Salido M, Fernandez-Segura E and Roomans GM: Neuropeptides, apoptosis and ion changes in prostate cancer. Methods of study and recent developments. Histol Histopathol 19(3): 951-961, 2004.
12. Schally AV, Comaru-Schally AM, Nagy A, Kovacs M, Szepeshazi K, Plonowski A, Varga JL and Halmos G: Hypothalamic hormones and cancer. Front Neuroendocrinol 22: 248-291, 2001.
13. Varvarigou AD, Scopinaro F, Leondiadis L, Corleto V, Schillaci O, DeVincentis G, Sourlingas TG, Sekeri-Pataryas KE, Evangelatos GP, Leonti A, Xanthopoulos S, Delle Fave G and Archimandritis SC: Synthesis, chemical, radiochemical and radiobiological evaluation of a new 99mTc-labelled bombesin-like peptide. Cancer Biother Radiopharm 17(3): 317-326, 2002.
14. Varvarigou A, Bouziotis P, Zikos C, Scopinaro F and De Vincentis G: Gastrin-releasing peptide (GRP) analogues for cancer imaging. Cancer Biother Radiopharm 19(2): 219-229, 2004.
15. Scopinaro F, Varvarigou AD, Ussof W, De Vincentis G, Sourlingas TG, Evangelatos GP, Datsteris J and Archimandritis SC: Technetium labeled bombesin-like peptide: preliminary report on breast cancer uptake in patients. Cancer Biother Radiopharm 17(3): 327-335, 2002.
16. Scopinaro F, Varvarigou A, Ussof W, De Vincentis G, Archimandritis S, Evangelatos G, Corleto V, Pulcini A, Capoccetti F, Remediani S and Massa R: Breast cancer take up 99mTc bombesin. A preliminary report. Tumori 88(3): S25-28, 2002.
17. 99mTc [13 Leu] bombesin and a new gamma camera, the imaging probe, are able to guide mammotome biopsy. Anticancer Res 23: 2139-2142, 2003.
18. Scopinaro F, De Vincentis G, Corazziari E, Massa R, Osti M, Pallotta N, Covotta A, Remediani S, Di Paolo M, Monteleone F and Varvarigou A: Detection of colon cancer with 99mTc-labeled bombesin derivative (99mTc-leu-13-BN1). Cancer Biother Radiopharmaceut 19(2): 245-252, 2004.
19. Scopinaro F, De Vincentis G, Varvarigou AD, Laurenti C, Iori F, Remediani S, Chiarini S and Stella S: 99mTc-bombesin detects prostate cancer and invasion of pelvic lymph nodes. Eur J Nucl Med Mol Imag 30(10): 1378-1382, 2003.
20. De Vincentis G, Scopinaro F, Varvarigou A, Ussof W, Schillaci O, Archimandritis S, Leondiadis L, Corleto V, Longo F and Delle Fave G: Phase I trial of technetium [LEU 13] bombesin as a cancer seeking agent. Possible scintigraphic guide for surgery? Tumori 88(3): S28-30, 2002.
21. De Vincentis G, Remediani S, Varvarigou AD, Di Santo G, Iori F, Laurenti C and Scopinaro F: Role of 99mTc-bombesin scan in diagnosis and staging of prostate cancer. Cancer Biother Radiopharmaceut 19(1): 81-84, 2004.
22. Zhang H, Chen J, Waldherr C, Hinni K, Waser B, Reubi JC and Maecke HR: Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors. Cancer Res 64(18): 6707-6715, 2004.
23. Scopinaro F, De Vincentis G, Banci M, Schilaci O, Di Loreto M, Danieli R, Ierardi M, De Paola AM, Gianni W and Massa R: In vivo study of a technetium labelled anti EGFR MoAb. Anticancer Res 17: 1761-1765, 1997.
24. Signore A, Annovazzi A, Chianelli M, Corsetti F, Van De Wiele C, Waterhouse RN and Scopinaro F: Peptide radiopharmaceuticals for diagnosis and therapy. Eur J Nucl Med 28: 1555-1565, 2001.
25. 111In-pentetreotide detection of gastrinoma before and after surgery. Anticancer Res 17: 1757-1760, 1997.
26. Schillaci O, Massa R and Scopinaro F: Indium-111-octreotide scintigraphy in the detection of insulinomas: importance of SPECT imaging. J Nucl Med 41: 459-462, 2000.
27. Schillaci O, Scopinaro F, Danieli R, Angeletti S, Tavolaro R, Annibale B, Cannas P, Marignani M, Centi Colella A and Delle Fave G: Single photon emission computerized tomography increases the sensitivity of indium-111-pentetreotide scintigraphy in detecting abdominal carcinoids. Anticancer Res 17: 1753-1756, 1997.
28. Khalkhali I, Diggles LE, Taillefer R, Vandestreek PR, Peller PJ and Abdel-Nabi HH: Procedure guideline for breast scintigraphy. J Nucl Med 40: 1233-1235, 1999.
29. Scopinaro F, Schillaci O, Ussof W, Nordling K, Capoferro R, De Vincentis G, Danieli R, Ierardi M, Picardi V, Tavolaro R and Centi Colella A: A three center study on the diagnostic accuracy of 99mTc-MIBI scintimammography. Anticancer Res 17: 1631-1634, 1997.
30. Tang C, Biemond I and Lamers CB: Expression of peptide receptors in human endocrine tumours of the pancreas. Gut 40(2): 267-271, 1997.
31. Bold RJ, Lowry PS, Ishizuka J, Battey JF, Townsend CM Jr and Thompson JC: Bombesin stimulates the in vitro growth of a human gastric cancer cell line. J Cell Physiol 161(3): 519-525, 1994.
32. Goris ML and Briandet PA: Mathematical deivations. In: Goris ML and Briandet PA (eds.). A Clinical and Mathematical Introduction to Computer Processing of Scintigraphic Images. Raven Press, New York, pp. 73-122, 1987.